Rapid Micro Biosystems, Inc.
General ticker "RPID" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $119.3M (TTM average)
Rapid Micro Biosystems, Inc. follows the US Stock Market performance with the rate: 31.3%.
Estimated limits based on current volatility of 5.1%: low 2.14$, high 2.37$
Factors to consider:
- Total employees count: 163 (-15.5%) as of 2024
- US accounted for 37.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Growth challenges, Marketing effectiveness, Labor/talent shortage/retention, Cybersecurity threats, Geopolitical risks
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.86$, 4.30$]
- 2026-12-31 to 2027-12-31 estimated range: [1.63$, 3.87$]
Financial Metrics affecting the RPID estimates:
- Positive: with PPE of -2.9 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -22.66 <= 0.07
- Positive: Investing cash flow per share per price, % of 10.45 > -0.65
- Negative: negative Industry operating income (median)
- Negative: 42.60 < Shareholder equity ratio, % of 44.36 <= 64.25
- Negative: Industry inventory ratio change (median), % of 0.82 > 0.31
Short-term RPID quotes
Long-term RPID plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $22.52MM | $28.05MM | $33.59MM |
| Operating Expenses | $79.08MM | $77.97MM | $80.98MM |
| Operating Income | $-56.56MM | $-49.92MM | $-47.39MM |
| Non-Operating Income | $4.13MM | $3.05MM | $0.31MM |
| Interest Expense | $0.00MM | $0.00MM | $1.09MM |
| R&D Expense | $12.82MM | $14.60MM | $13.60MM |
| Income(Loss) | $-52.44MM | $-46.87MM | $-47.08MM |
| Taxes | $0.03MM | $0.02MM | $0.04MM |
| Profit(Loss)* | $-52.47MM | $-46.89MM | $-47.12MM |
| Stockholders Equity | $117.99MM | $75.35MM | $33.21MM |
| Inventory | $19.96MM | $20.20MM | $17.59MM |
| Assets | $143.45MM | $98.17MM | $74.85MM |
| Operating Cash Flow | $-45.08MM | $-44.15MM | $-31.06MM |
| Capital expenditure | $1.84MM | $1.36MM | $0.85MM |
| Investing Cash Flow | $42.15MM | $36.66MM | $14.33MM |
| Financing Cash Flow | $0.15MM | $0.20MM | $19.77MM |
| Earnings Per Share** | $-1.22 | $-1.08 | $-1.05 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.